Danaher Corporation $DHR Shares Acquired by Hsbc Holdings PLC

Hsbc Holdings PLC grew its position in shares of Danaher Corporation (NYSE:DHR) by 5.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,443,380 shares of the conglomerate’s stock after purchasing an additional 73,115 shares during the quarter. Hsbc Holdings PLC owned approximately 0.21% of Danaher worth $274,998,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in Danaher during the second quarter valued at $10,492,520,000. Norges Bank acquired a new position in shares of Danaher in the fourth quarter worth about $2,177,106,000. Jupiter Topco LLC purchased a new stake in shares of Danaher during the 2nd quarter worth about $1,456,317,000. Generation Investment Management LLP acquired a new stake in shares of Danaher during the 2nd quarter valued at about $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in shares of Danaher in the 2nd quarter valued at about $993,846,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. TD Cowen reduced their price target on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Evercore restated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Guggenheim decreased their target price on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research report on Wednesday, July 22nd. Finally, Stifel Nicolaus dropped their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Trading Down 0.1%

DHR stock opened at $207.46 on Monday. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The business’s 50-day moving average is $201.74 and its 200 day moving average is $192.14. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market cap of $145.84 billion, a price-to-earnings ratio of 36.85, a PEG ratio of 2.59 and a beta of 0.78.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. During the same quarter in the prior year, the firm earned $0.77 earnings per share. The business’s revenue was up 5.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.